{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T22:45:34Z","timestamp":1698533134188},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"vor","delay-in-days":2402,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>OBJECTIVE\u2003Traditional treatment modalities of diffuse non\u2010toxic goitre are thyroid hormone suppression or surgery. When treating nodular non\u2010toxic goitre with <jats:sup>131<\/jats:sup>I treatment a reduction in thyroid volume to about 50% has been observed. In the present study we evaluated the effect of <jats:sup>131<\/jats:sup>I treatment of diffuse non\u2010toxic goitre.<\/jats:p><jats:p>DESIGN\u2003Retrospective study of patients treated for a diffuse non\u2010toxic goitre and followed by evaluation of thyroid volume measured by ultrasound.<\/jats:p><jats:p>PATIENTS\u2003Ten selected patients from our out\u2010patient clinic with diffuse non\u2010toxic goitre.<\/jats:p><jats:p>MEASUREMENTS\u2003Thyroid volume was measured by ultrasound and thyroid function by serum values of T4, T3, T3 uptake ratio, TSH, TSH receptor antibodies and thyroid peroxidase antibodies (anti\u2010TPO). Measurements were performed before and 1, 3, 6 and 12 months (and 18 months (<jats:italic>n<\/jats:italic>=7), thyroid volume measured in six patients)) after <jats:sup>131<\/jats:sup>I treatment.<\/jats:p><jats:p>RESULTS\u2003Thyroid volume declined in all patients from median 41 (range 27\u2013160)\u2003ml to 20 (range 9\u2013108)\u2003ml over 1 year, a reduction of 47%. One patient developed transient and one persistent hypothyroidism in the follow\u2010up period. Both had elevated anti\u2010TPO levels before treatment (331 and 9185\u2003U\/ml) and demonstrated titre increases of 2.5 and 30 times after 3 and 6 months, respectively. Pretreatment values were reached after 1 year. The other eight patients had normal anti\u2010TPO levels and free T4 and T3 indices did not change during follow\u2010up, whereas serum TSH levels demonstrated upward trends within the normal range (<jats:italic>P<\/jats:italic>&lt;0.05). TSH receptor antibodies were normal and remained so in all patients.<\/jats:p><jats:p>CONCLUSION\u2003S<jats:sup>131<\/jats:sup>I treatment of diffuse non\u2010toxic goitre reduces thyroid volume by approximately 50% within 12\u201318 months. Hypothyroidism, during a limited follow\u2010up period, developed only in patients with positive anti\u2010TPO levels before treatment.<\/jats:p>","DOI":"10.1046\/j.1365-2265.1997.1760987.x","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T20:05:45Z","timestamp":1068235545000},"page":"493-496","source":"Crossref","is-referenced-by-count":13,"title":["Thyroid volume and function after <sup>131<\/sup>I treatment of diffuse non\u2010toxic goitre"],"prefix":"10.1111","volume":"46","author":[{"given":"B.","family":"Nygaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Veje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E. M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,29]]},"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1997.1760987.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1997.1760987.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1997.1760987.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:23:01Z","timestamp":1698402181000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1997.1760987.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1046\/j.1365-2265.1997.1760987.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1997.1760987.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}